| Donald J Rourke, PT | |
|
801 Merrick Ave, East Meadow, NY 11554 | |
| (516) 393-8900 | |
| (516) 393-8969 |
| Full Name | Donald J Rourke |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 801 Merrick Ave, East Meadow, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043277866 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 0150861 (New York) | Primary |
| Provider Name | Sports Physical Therapy Occupational Therapy And Rehabilitation Servic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770540593 PECOS PAC ID: 0446140446 Enrollment ID: O20040315001603 |
News Archive
House and Senate negotiators appear to be making progress towards stiffer regulations over the type of drugs that caused last year's outbreak. In other Capitol Hill news, the GOP pushes to repeal a tax on medical devices, and rural health care providers ask for more time to meet electronic health record deadlines.
The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Dementias (AFTD) announced today the recipients of their third annual research award, Frontotemporal Dementia Drug Discovery Program. The goal of the program is to accelerate the development of novel therapies for frontotemporal dementia (FTD). The program will provide a total of $1,200,000 in research grants over four years.
Decoding the DNA of patients with advanced breast cancer has allowed scientists to identify distinct cancer "signatures" that could help predict which women are most likely to benefit from estrogen-lowering therapy, while sparing others from unnecessary treatment.
Dmitry Temiakov, PhD, a biochemist at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine, has received a five-year, $1.5 million grant from the National Institutes of Health (NIH) to fund research into the molecular mechanisms that control gene expression in mitochondria, the organelles that are the "power plants" of cellular activity.
BioTrends is pleased to announce the publication of a new syndicated report, TreatmentTrends: Multiple Sclerosis. This report covers the use of disease-modifying agents for the treatment of multiple sclerosis, as well as attitudes and perceptions toward these products, advantages and disadvantages, ideal patient types, barriers to growth and expected future use.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donald J Rourke, PT 801 Merrick Ave, East Meadow, NY 11554 Ph: (516) 393-8900 | Donald J Rourke, PT 801 Merrick Ave, East Meadow, NY 11554 Ph: (516) 393-8900 |
News Archive
House and Senate negotiators appear to be making progress towards stiffer regulations over the type of drugs that caused last year's outbreak. In other Capitol Hill news, the GOP pushes to repeal a tax on medical devices, and rural health care providers ask for more time to meet electronic health record deadlines.
The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Dementias (AFTD) announced today the recipients of their third annual research award, Frontotemporal Dementia Drug Discovery Program. The goal of the program is to accelerate the development of novel therapies for frontotemporal dementia (FTD). The program will provide a total of $1,200,000 in research grants over four years.
Decoding the DNA of patients with advanced breast cancer has allowed scientists to identify distinct cancer "signatures" that could help predict which women are most likely to benefit from estrogen-lowering therapy, while sparing others from unnecessary treatment.
Dmitry Temiakov, PhD, a biochemist at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine, has received a five-year, $1.5 million grant from the National Institutes of Health (NIH) to fund research into the molecular mechanisms that control gene expression in mitochondria, the organelles that are the "power plants" of cellular activity.
BioTrends is pleased to announce the publication of a new syndicated report, TreatmentTrends: Multiple Sclerosis. This report covers the use of disease-modifying agents for the treatment of multiple sclerosis, as well as attitudes and perceptions toward these products, advantages and disadvantages, ideal patient types, barriers to growth and expected future use.
› Verified 4 days ago
Gerigymllc Physical Therapist Medicare: Medicare Enrolled Practice Location: 2147 4th St, East Meadow, NY 11554 Phone: 516-445-4935 | |
Robert Dimonte, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 Merrick Ave, East Meadow, NY 11554 Phone: 516-393-8900 | |
Thomas Maguffin, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 801 Merrick Ave, East Meadow, NY 11554 Phone: 516-393-8900 | |
Laura A Richardson, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 801 Merrick Ave, East Meadow, NY 11554 Phone: 516-393-8900 | |
Nicole Tong, PT,DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 801 Merrick Ave, East Meadow, NY 11554 Phone: 516-393-8900 | |
Sloan Yoselowitz, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2201 Hempstead Tpke, Nassau University Medical Center, East Meadow, NY 11554 Phone: 516-572-6131 |